Sign in

CIK 0001253689 · Non-accelerated filer<br>Smaller reporting company

CRESCENT BIOPHARMA, INC.

Sign in to watch
Ticker
CBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Cayman Islands
Entity type
operating
Phone
617-430-5595
Business address
300 FIFTH AVENUE, WALTHAM, MA, 02451
Former names
GLYCOMIMETICS INC
  1. 4 Planned sale See Remarks sold 240 shares at $17.90 ($4,296)
  2. 4 Planned sale Chief Scientific Officer sold 658 shares at $17.90 ($11,778)
  3. 4 Planned sale Chief Medical Officer sold 623 shares at $17.90 ($11,152)
  4. 4 Planned sale Chief Financial Officer sold 568 shares at $17.90 ($10,167)
  5. 4 Planned sale See Remarks sold 620 shares at $17.90 ($11,098)
  6. 4 Planned sale Chief Executive Officer sold 9,447 shares at an average $16.91 ($159,775)
  7. 4 Planned sale President and COO sold 4,570 shares at an average $16.90 ($77,235)
  8. 4 Open-market buy Director bought 853,450 shares at $14.50 ($12,375,025)
  9. 4 Planned sale See Remarks sold 465 shares at $17.99 ($8,365)
  10. 4 Planned sale Chief Scientific Officer sold 1,288 shares at $17.99 ($23,171)
  11. 4 Planned sale Chief Financial Officer sold 1,112 shares at $17.99 ($20,005)
  12. 4 Planned sale See Remarks sold 1,218 shares at $17.99 ($21,912)
  13. 4 Planned sale Chief Medical Officer sold 1,219 shares at $17.99 ($21,930)
  14. 4 Planned sale President and COO sold 20,549 shares at $17.99 ($369,677)
  15. 4 Planned sale Chief Executive Officer sold 42,305 shares at $17.99 ($761,067)
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 1 of 15 · 293 filings